
AAO 2025: Insights on the PULSAR extension study
Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution
Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting in Orlando, Florida, the Eye Care Network spoke with Jean-Francois Korobelnik, MD. Prof Korobelnik, of Hôpital Pellegrin and CHU de Bordeaux, Bordeaux, France, is an editorial advisor for
In this video, Prof Korobelnik discusses the fluid resolution outcomes observed in the study, describes the accompanying functional outcomes and patient response, addresses possible areas of future study and shares his perspective on the changing landscape of retinal therapies.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.